DALACINE Side Effects

6638079-9 | Abdominal Pain, Chest Pain, Myocardial Ischaemia, Tachycardia, Ventricular Extrasystoles
on Mar 05, 2010 Female patient from FRANCE , 51 years of age, was diagnosed with anaesthesia procedure and was treated with Dalacine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), chest pain (What is chest pain?), myocardial ischaemia, tachycardia, ventricular extrasystoles. Dalacine dosage: 10 Ml.

6624092-4 | Anaphylactic Shock, Myocardial Infarction
Patient was taking Dalacine (View Usage). Patient had the following side effects: anaphylactic shock, myocardial infarction on Feb 26, 2010 from FRANCE Additional patient health information: Female patient , 51 years of age, was diagnosed with anaesthesia procedure and. Dalacine dosage: 10 Ml.

6585112-9 | Agranulocytosis, Hepatocellular Injury
Adverse event was reported on Feb 08, 2010 by a Female patient taking Dalacine (View Usage) (Dosage: 300 Mg, 2x/day) was diagnosed with pustular psoriasis and. Location: FRANCE , 25 years of age, weighting 169.8 lb, After Dalacine was administered, patient had the following side effects: agranulocytosis, hepatocellular injury. During the same period patient was treated with RIFADIN (1 Df, 2x/day) (View Rifadin Review and Rifadin Label ). Patient was hospitalized.

6579945-2 | Blood Bilirubin Increased, Liver Injury
on Feb 01, 2010 Male patient from FRANCE , 39 years of age, was treated with Dalacine (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, liver injury. Dalacine dosage: Unk. During the same period patient was treated with NEXIUM (40 Mg Daily) (View Nexium Review and Nexium Label ), OFLOCET (200 Mg, 2x/day) (View Oflocet Review and Oflocet Label ), LASILIX (Unk) (View Lasilix Review and Lasilix Label ). Patient was hospitalized.


6544856-5 | Angioedema, Paraesthesia
on Jan 11, 2010 Female patient from FRANCE , 48 years of age, was diagnosed with tooth infection and was treated with Dalacine (View Usage). Patient had the following side effects: angioedema, paraesthesia. Dalacine dosage: 1 Df, 1x/day. During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), FLAGYL (View Flagyl Review and Flagyl Label ).

6473770-9 | Renal Failure Acute
Patient was taking Dalacine (View Usage). After Dalacine was administered, patient had the following side effects: renal failure acute on Nov 27, 2009 from FRANCE Additional patient health information: Male patient , 81 years of age, . Dalacine dosage: 900 Mg, 1x/day. During the same period patient was treated with PREVISCAN (Unk) (View Previscan Review and Previscan Label ), FUSIDIC ACID (Unk) (View Fusidic Acid Review and Fusidic Acid Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), TRIVASTAL (View Trivastal Review and Trivastal Label ). Patient was hospitalized.

6466918-3 | Cytolytic Hepatitis, Inflammation, Renal Failure Acute, Rhabdomyolysis
Adverse event was reported on Nov 20, 2009 by a Male patient taking Dalacine (View Usage) (Dosage: 600 Mg, 4x/day) . Location: FRANCE , 67 years of age, Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, inflammation, renal failure acute, rhabdomyolysis. During the same period patient was treated with FUCIDINE CAP (500 Mg, 3x/day) (View Fucidine Cap Review and Fucidine Cap Label ), LODOZ (Unk) (View Lodoz Review and Lodoz Label ), NEXIUM (20 Mg, Unk) (View Nexium Review and Nexium Label ), TENORDATE (Unk) (View Tenordate Review and Tenordate Label ), VOLTAREN (Unk) (View Voltaren Review and Voltaren Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), INNOHEP (Unk) (View Innohep Review and Innohep Label ). Patient was hospitalized.

6421639-8 | Cholestasis
on Oct 21, 2009 Female patient from FRANCE , 70 years of age, was diagnosed with infection (What is infection?), anxiety (What is anxiety?), type 2 diabetes mellitus, hypovitaminosis, hypokalaemia, cardiovascular event prophylaxis and was treated with Dalacine (View Usage). Patient had the following side effects: cholestasis. Dalacine dosage: 600 Mg, 3x/day. During the same period patient was treated with TIENAM (500 Mg, 3x/day) (View Tienam Review and Tienam Label ), FOSFOCINE (4 G, 3x/day) (View Fosfocine Review and Fosfocine Label ), ATARAX (100 Mg, 1x/day) (View Atarax Review and Atarax Label ), NOVONORM (2 Mg, 2x/day) (View Novonorm Review and Novonorm Label ), INSULIN DETEMIR (View Insulin Detemir Review and Insulin Detemir Label ), CACIT D3 (View Cacit D3 Review and Cacit D3 Label ), DIFFU K (600 Mg, 2x/day) (View Diffu K Review and Diffu K Label ), KARDEGIC (160 Mg, 1x/day) (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6421547-2 | Cholangitis
on Oct 21, 2009 Female patient from FRANCE , 73 years of age, was diagnosed with osteoarthritis (What is osteoarthritis?), gastrooesophageal reflux disease and was treated with Dalacine (View Usage). After Dalacine was administered, patient had the following side effects: cholangitis. Dalacine dosage: . During the same period patient was treated with AUGMENTIN (View Augmentin Review and Augmentin Label ), CIFLOX (View Ciflox Review and Ciflox Label ), NEXIUM (View Nexium Review and Nexium Label ), ALDACTAZINE (View Aldactazine Review and Aldactazine Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6394126-3 | Erythema Multiforme, Hepatitis
Patient was taking Dalacine (View Usage). Patient experienced the following unwanted or unexpected effects: erythema multiforme, hepatitis (What is hepatitis?) on Sep 28, 2009 from FRANCE Additional patient health information: Female patient , 78 years of age, was diagnosed with bacterial infection (What is bacterial infection?), sepsis (What is sepsis?) and. Dalacine dosage: Unk. During the same period patient was treated with TAVANIC (Unk) (View Tavanic Review and Tavanic Label ). Patient was hospitalized.

6308213-9 | Cytolytic Hepatitis, Inflammation, Renal Failure Acute, Rhabdomyolysis
Adverse event was reported on Aug 04, 2009 by a Female patient taking Dalacine (View Usage) (Dosage: 600 Mg, 4x/day) . Location: FRANCE , 67 years of age, Patient had the following side effects: cytolytic hepatitis, inflammation, renal failure acute, rhabdomyolysis. During the same period patient was treated with FUCIDINE CAP (500 Mg, 3x/day) (View Fucidine Cap Review and Fucidine Cap Label ), LODOZ (Unk) (View Lodoz Review and Lodoz Label ), NEXIUM (20 Mg, Unk) (View Nexium Review and Nexium Label ), TENORDATE (Unk) (View Tenordate Review and Tenordate Label ), VOLTAREN (Unk) (View Voltaren Review and Voltaren Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), INNOHEP (Unk) (View Innohep Review and Innohep Label ). Patient was hospitalized.

6270531-0 | Cytolytic Hepatitis
on Jul 07, 2009 Female patient from FRANCE , 23 years of age, was diagnosed with subcutaneous abscess, back pain (What is back pain?) and was treated with Dalacine (View Usage). After Dalacine was administered, patient had the following side effects: cytolytic hepatitis. Dalacine dosage: Unk. During the same period patient was treated with RIFADIN (Unk) (View Rifadin Review and Rifadin Label ), PARACETAMOL (20 G, In 5 Days) (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6220902-3 | C-reactive Protein Increased, Decubitus Ulcer, Eosinophilia, Face Oedema, Pyrexia, Rash Maculo-papular
on May 29, 2009 Female patient from FRANCE , 86 years of age, was diagnosed with osteomyelitis, staphylococcal infection (What is staphylococcal infection?) and was treated with Dalacine (View Usage). Patient experienced the following unwanted or unexpected effects: c-reactive protein increased, decubitus ulcer, eosinophilia, face oedema, pyrexia, rash maculo-papular. Dalacine dosage: Unk. During the same period patient was treated with RIFADIN (600 Mg, 2x/day) (View Rifadin Review and Rifadin Label ), VANCOMYCIN (Unk) (View Vancomycin Review and Vancomycin Label ), GENTAMYCIN SULFATE (Unk) (View Gentamycin Sulfate Review and Gentamycin Sulfate Label ). Patient was hospitalized.

6217251-6 | Cheilitis, Eosinophilia, Gamma-glutamyltransferase Increased, Rash Maculo-papular
Patient was taking Dalacine (View Usage). Patient had the following side effects: cheilitis, eosinophilia, gamma-glutamyltransferase increased, rash maculo-papular on May 25, 2009 from FRANCE Additional patient health information: Female patient , 79 years of age, . Dalacine dosage: 1 Df, 2x/day. During the same period patient was treated with NEXEN (1 Df, 1x/day) (View Nexen Review and Nexen Label ), SODIUM BICARBONATE (Unk) (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), FUNGIZONE (Unk) (View Fungizone Review and Fungizone Label ). Patient was hospitalized.

6209909-X | Eczema, Rash Maculo-papular
Adverse event was reported on May 18, 2009 by a Female patient taking Dalacine (View Usage) (Dosage: Unk) was diagnosed with surgery (What is surgery?) and. Location: FRANCE , 63 years of age, After Dalacine was administered, patient had the following side effects: eczema (What is eczema?), rash maculo-papular. During the same period patient was treated with BRISTOPEN (Unk) (View Bristopen Review and Bristopen Label ), SUFENTA PRESERVATIVE FREE (Unk) (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ), HYPNOVEL (Unk) (View Hypnovel Review and Hypnovel Label ), DIPRIVAN (Unk) (View Diprivan Review and Diprivan Label ), HEXOMEDINE (Unk) (View Hexomedine Review and Hexomedine Label ), GENTALLINE (Unk) (View Gentalline Review and Gentalline Label ). Patient was hospitalized.

5933321-1 | Rash, Renal Failure
on Oct 16, 2008 Female patient from FRANCE , 70 years of age, was diagnosed with cholecystitis and was treated with Dalacine (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?), renal failure. Dalacine dosage: . During the same period patient was treated with OXCARBAZEPINE (View Oxcarbazepine Review and Oxcarbazepine Label ). Patient was hospitalized.

5902049-6 | Dermatitis Exfoliative, Nephritis, Renal Disorder
on Sep 18, 2008 Female patient from FRANCE , weighting 103.6 lb, was diagnosed with surgery (What is surgery?), cholecystitis, convulsion and was treated with Dalacine (View Usage). Patient had the following side effects: dermatitis exfoliative, nephritis, renal disorder. Dalacine dosage: . During the same period patient was treated with TRILEPTAL (View Trileptal Review and Trileptal Label ), SINTROM (View Sintrom Review and Sintrom Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), HYTACAND (View Hytacand Review and Hytacand Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ). Patient was hospitalized.

5722097-9 | Dysgeusia, Headache, Hypertonia, Intraocular Pressure Increased, Nausea, Photophobia, Skin Disorder, Vertigo
Patient was taking Dalacine (View Usage). After Dalacine was administered, patient had the following side effects: dysgeusia, headache (What is headache?), hypertonia, intraocular pressure increased, nausea (What is nausea?), photophobia, skin disorder, vertigo on Apr 17, 2008 from FRANCE Additional patient health information: Female patient , 44 years of age, was diagnosed with eye infection toxoplasmal and. Dalacine dosage: Daily Dose:1gram. During the same period patient was treated with MALOCIDE (Daily Dose:1200mg) (View Malocide Review and Malocide Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), DIFFU K (View Diffu K Review and Diffu K Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MAXIDROL (View Maxidrol Review and Maxidrol Label ). Patient was hospitalized.

5717174-2 | Renal Failure Acute, Vascular Purpura
Adverse event was reported on Apr 14, 2008 by a Male patient taking Dalacine (View Usage) (Dosage: ) . Location: FRANCE , 80 years of age, Patient experienced the following unwanted or unexpected effects: renal failure acute, vascular purpura. During the same period patient was treated with METRONIDAZOLE HCL (View Metronidazole Hcl Review and Metronidazole Hcl Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), OFLOCET (View Oflocet Review and Oflocet Label ). Patient was hospitalized.

5651481-7 | Dehydration, No Adverse Event, Renal Failure Acute, Weight Decreased
on Feb 25, 2008 Male patient from FRANCE , 77 years of age, was diagnosed with abscess (What is abscess?) and was treated with Dalacine (View Usage). Patient had the following side effects: dehydration, no adverse event, renal failure acute, weight decreased. Dalacine dosage: Text:6 Df. During the same period patient was treated with FUCIDINE CAP (Text:6 Df) (View Fucidine Cap Review and Fucidine Cap Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), LASILIX (View Lasilix Review and Lasilix Label ), CORDARONE (View Cordarone Review and Cordarone Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PARIET (View Pariet Review and Pariet Label ), EFFEXOR (View Effexor Review and Effexor Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ).

5647643-5 | Renal Failure Acute
on Feb 25, 2008 Male patient from FRANCE , 77 years of age, was diagnosed with abscess (What is abscess?), hyperuricaemia and was treated with Dalacine (View Usage). After Dalacine was administered, patient had the following side effects: renal failure acute. Dalacine dosage: . During the same period patient was treated with FUCIDINE CAP (View Fucidine Cap Review and Fucidine Cap Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), LASIX (View Lasix Review and Lasix Label ), CORDARONE (View Cordarone Review and Cordarone Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), EFFEXOR (View Effexor Review and Effexor Label ), PARIET (View Pariet Review and Pariet Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ). Patient was hospitalized.

5565527-8 | Face Oedema, Hepatitis, Hypersensitivity, Inflammation, Prurigo, Pyrexia, Rash, Rash Erythematous
Patient was taking Dalacine (View Usage). Patient experienced the following unwanted or unexpected effects: face oedema, hepatitis (What is hepatitis?), hypersensitivity, inflammation, prurigo, pyrexia, rash (What is rash?), rash erythematous on Dec 06, 2007 from FRANCE Additional patient health information: Female patient , 62 years of age, was diagnosed with staphylococcal infection (What is staphylococcal infection?) and. Dalacine dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), LAMISIL (View Lamisil Review and Lamisil Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), IMOVANE (View Imovane Review and Imovane Label ), FLUOXETINE HYDROCHLORIDE (View Fluoxetine Hydrochloride Review and Fluoxetine Hydrochloride Label ), INEXIUM (View Inexium Review and Inexium Label ), LEPTICUR (View Lepticur Review and Lepticur Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ). Patient was hospitalized.

5471966-6 | Renal Failure Acute
Adverse event was reported on Sep 17, 2007 by a Male patient taking Dalacine (View Usage) (Dosage: Text:6 Df) was diagnosed with abscess (What is abscess?) and. Location: FRANCE , 77 years of age, Patient had the following side effects: renal failure acute. During the same period patient was treated with FUCIDINE (Text:6 Df) (View Fucidine Review and Fucidine Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), LASIX (View Lasix Review and Lasix Label ), CORDARONE (View Cordarone Review and Cordarone Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), EFFEXOR (View Effexor Review and Effexor Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ). Patient was hospitalized.

5412988-0 | Renal Failure Acute
on Aug 02, 2007 Male patient from FRANCE , 77 years of age, was diagnosed with abscess (What is abscess?), hyperuricaemia and was treated with Dalacine (View Usage). After Dalacine was administered, patient had the following side effects: renal failure acute. Dalacine dosage: . During the same period patient was treated with FUCIDINE (View Fucidine Review and Fucidine Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), LASIX (View Lasix Review and Lasix Label ), CORDARONE (View Cordarone Review and Cordarone Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), EFFEXOR (View Effexor Review and Effexor Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ). Patient was hospitalized.

5396029-X | Renal Failure Acute
on Jul 12, 2007 Male patient from FRANCE , 77 years of age, was diagnosed with abscess (What is abscess?), hyperuricaemia and was treated with Dalacine (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Dalacine dosage: . During the same period patient was treated with FUCIDINE (View Fucidine Review and Fucidine Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), LASIX (View Lasix Review and Lasix Label ), CORDARONE (View Cordarone Review and Cordarone Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), EFFEXOR (View Effexor Review and Effexor Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ). Patient was hospitalized.

5254592-3 | Diarrhoea, Hyperglycaemia, Oesophageal Discomfort, Platelet Count Increased, Rash, Vomiting
Patient was taking Dalacine (View Usage). Patient had the following side effects: diarrhoea, hyperglycaemia, oesophageal discomfort, platelet count increased, rash (What is rash?), vomiting on Feb 20, 2007 from FRANCE Additional patient health information: Female patient , 71 years of age, was diagnosed with infection (What is infection?) and. Dalacine dosage: . Patient was hospitalized.

5241998-1 | Oedema Peripheral
Adverse event was reported on Feb 08, 2007 by a Male patient taking Dalacine (View Usage) (Dosage: Daily Dose:2400mg) was diagnosed with intervertebral discitis and. Location: FRANCE , weighting 147.7 lb, After Dalacine was administered, patient had the following side effects: oedema peripheral. During the same period patient was treated with OFLOCET (Daily Dose:400) (View Oflocet Review and Oflocet Label ), CLOXACILLIN SODIUM (View Cloxacillin Sodium Review and Cloxacillin Sodium Label ), OMEPRAZOLE (Daily Dose:20mg) (View Omeprazole Review and Omeprazole Label ).

5227812-9 | Oedema Peripheral
on Jan 23, 2007 Male patient from FRANCE , 77 years of age, was diagnosed with intervertebral discitis and was treated with Dalacine (View Usage). Patient experienced the following unwanted or unexpected effects: oedema peripheral. Dalacine dosage: . During the same period patient was treated with CLOXACILLIN SODIUM (View Cloxacillin Sodium Review and Cloxacillin Sodium Label ), OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ).

5219877-5 | Neurological Symptom, Renal Failure Acute, Stevens-johnson Syndrome
on Jan 15, 2007 Female patient from FRANCE , 49 years of age, was diagnosed with fasciitis and was treated with Dalacine (View Usage). Patient had the following side effects: neurological symptom, renal failure acute, stevens-johnson syndrome. Dalacine dosage: . During the same period patient was treated with LASIX (Daily Dose:1gram) (View Lasix Review and Lasix Label ), OFLOCET (View Oflocet Review and Oflocet Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ).

5216343-8 | Renal Failure Acute, Stevens-johnson Syndrome
Patient was taking Dalacine (View Usage). After Dalacine was administered, patient had the following side effects: renal failure acute, stevens-johnson syndrome on Jan 03, 2007 from FRANCE Additional patient health information: Female patient , 49 years of age, . Dalacine dosage: . During the same period patient was treated with LASIX (Daily Dose:1gram) (View Lasix Review and Lasix Label ), OFLOCET (View Oflocet Review and Oflocet Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ).

5201398-7 | Abortion, Abortion Spontaneous, Pregnancy
Adverse event was reported on Dec 27, 2006 by a Female patient taking Dalacine (View Usage) (Dosage: Text:6 Df) . Location: FRANCE , 36 years of age, Patient experienced the following unwanted or unexpected effects: abortion (What is abortion?), abortion spontaneous, pregnancy (What is pregnancy?). During the same period patient was treated with TRIATEC (Daily Dose:5mg) (View Triatec Review and Triatec Label ), OFLOCET (Text:2df) (View Oflocet Review and Oflocet Label ), INSULIN (View Insulin Review and Insulin Label ), XALATAN (View Xalatan Review and Xalatan Label ), COSOPT (View Cosopt Review and Cosopt Label ).

5200225-1 | Hypersensitivity, Interstitial Lung Disease, Multi-organ Failure, Pyrexia, Rash Maculo-papular, Respiratory Distress
on Dec 26, 2006 Female patient from FRANCE , 34 years of age, weighting 114.6 lb, was diagnosed with toxoplasmosis and was treated with Dalacine (View Usage). Patient had the following side effects: hypersensitivity, interstitial lung disease, multi-organ failure, pyrexia, rash maculo-papular, respiratory distress. Dalacine dosage: . During the same period patient was treated with KALETRA (View Kaletra Review and Kaletra Label ), ABACAVIR SULFATE/LAMIVUDINE (Text:1 Dose Form; 1 Dose Form-freq:frequency: Daily) (View Abacavir Sulfate/lamivudine Review and Abacavir Sulfate/lamivudine Label ), SULFADIAZINE (View Sulfadiazine Review and Sulfadiazine Label ), PYRIMETHAMINE TAB (View Pyrimethamine Tab Review and Pyrimethamine Tab Label ).